InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Lee Jacks. Director active across 2 companies, notably G1 Therapeutics, Inc.. Aggregated, 5 reports have been published. Activity tracked since 15 June 2023. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Lee Jacks is a declarant linked to G1 Therapeutics, Inc. and Vaxcyte, Inc., where he is a Director. The 5 filings in the recent sample run from 2023-06-16 to 2025-06-16, with the modal transaction nature shown as Attribution; both buy and sell amounts are 0 EUR in this sample.